31.01.2023 • NewsColorconCoatingsExcipients

Colorcon to Acquire Healthcare Packaging Firm Airnov

Colorcon, a US-based globally active manufacturer of pharmaceutical film coatings and specialty excipients, has signed a Put agreement to purchase Airnov Healthcare Packaging from compatriot private equity firm Arsenal Capital Partners.

The company headquartered at Harleysville, Pennsylvania, said the transaction, which is subject to French works council review as well as regulatory approvals, could close during the current first quarter.

Based in France’s Loire valley, Airnov provides critical healthcare industries with high-quality, controlled atmosphere packaging designed to protect products from moisture and oxygen.

With a portfolio including customizable, high quality drop-in products (canisters and packets), integrated desiccant systems and specially designed plastic bottles containing oxygen barrier materials, the business with manufacturing facilities in the US, France, China and India employs around 700 people.

Airnov site © Colorcon
Airnov site © Colorcon

Colorcon CEO Simon Tasker said the proposed acquisition “presents a good match for our companies, as a key strength of Colorcon is the breadth of customer relationships across the pharmaceutical industry, including contacts at all levels in R&D, supply chain, and procurement.”

Tasker said the two portfolios are complementary, and a deal would offer synergies in terms of technical, customer and regulatory support to accelerate customers’ product development and commercialization, in particular as regards speed to market.

Matthias Brommer, president and managing director of Airnov, said that being acquired by Colorcon ownership would bring improved geographic coverage to the company and provide added value for its customers through its pharma focus and complementary product portfolio.

Author: Dede Williams, Freelance Journalist

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

most read

Photo
15.01.2025 • News

Global Outlook on Bio-based Polymers

It is important to examine the current state of bio-based polymers. This includes the rapidly growing production capacity, significant investments currently underway in China, Europe, and the Middle East, and the new political conditions in Europe that are driving demand for biodegradable polymers.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.